Deepa Prasad Appointed CFO of Secretome Therapeutics

Secretome Therapeutics, a biotechnology company developing first-in-class therapeutics derived from neonatal mesenchymal stem cells (nMSC) for the treatment of underserved diseases, today announced the appointment of Deepa Prasad as Chief Financial Officer.

“Deepa Prasad brings a wealth of knowledge through her combination of investment banking, operations, and venture capital experience in the life science industry,” said Vinny Jindal, President and Chief Executive Officer of Secretome Therapeutics. “Deepa’s history assisting companies in financings, partnerships, and corporate strategy will be invaluable as we advance our therapies into clinical trials, and we are thrilled to have her on our team.”

“I am truly excited to be joining Secretome at this pivotal time in the company’s history. I believe that secretomes represent a true breakthrough in the field of cell-based therapy, and I look forward to helping Secretome transform the way we treat diseases,” said Ms. Deepa Prasad.

Ms. Prasad brings more than 20 years of financial and operational expertise. She most recently served as President and CEO of vTv Therapeutics where she refocused operations, secured research initiation and helped raise $35M in financing. Previous to vTv, she was General Partner at WestRiver Group where she led healthcare investments in numerous companies, including Design Therapeutics. Ms. Prasad has also held senior positions at numerous public and private companies, including Blue Shield, Optum, and Coherus Biosciences. She began her career in biotech investment banking executing private placements and buy-side/sell-side M&A. She holds an M.B.A. from the Kellogg School of Management at Northwestern University and a B.S. in Business Administration from UC Berkeley.

She currently serves on the Board of Directors at Design Therapeutics and as Executive Director of the Robinson Life Sciences, Business and Entrepreneurship Program at UC Berkeley.

Other Executives In the News

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Executives on the Move

Dr. Val Kolesnitchenko brings extensive ophthalmology experience in clinical practice and industry to new therapeutics for the aging eye.
These strategic appointments signify a significant milestone for BRIJ Medical as they usher in a new era of post-surgical and trauma incision care with proven technologies that minimize wound complications and scarring.
Dr. Eckhard von Keutz has extensive experience in designing and conducting preclinical/toxicological studies, and toxicological risk assessment and management.
David Kroekel has more than 35 years of experience in medical device, combination product operations, and product development.
Dr. Konstantin Kousoulas, a leading virologist will work to further Rational Vaccines core mission of eradicating the world of the herpes simplex virus. "Dr. Kousoulas...

By using this website you agree to accept Medical Device News Magazine Privacy Policy